The so-called pinch-off syndrome is observed in up to 1% of all central venous catheters (CVCs), and is a valuable warning prior to fragmentation, which occurs in approximately 40% of the respective ...

Using two central venous catheters on one patient at the same time can significantly increase the risk of developing a central line-associated bloodstream infection, according to a study published ...

Peripherally inserted central catheters (PICCs) are frequently used to obtain central venous access for patients in acute care, home care and skilled nursing care. PICCs are a reliable alternative to ...

A peripherally inserted central catheter (PICC) is a small, thin, and flexible tube inserted into a vein in the upper arm and guided into the superior vena cava to deliver intravenous fluids, ...

The business research study titled “Central Venous Catheters Market” provides a complete analysis on this market, covering market trends, size, share and future prospects. The report uses statistical ...

To report the experience of peripheral insertion of double-lumen central catheters (PIDLCC) in preterm and term newborn infants and to analyze the technical characteristics of the procedure and any ...

S. boulardii Safe for Children with Acute Diarrhea What is the incidence of probiotic-associated central line infections in the ICU — and do the risks posed by these infections outweigh the benefits ...

Please provide your email address to receive an email when new articles are posted on . The FDA announced that Teleflex and Arrow International LLC are recalling both the Arrow MAC Two-Lumen Central ...

Tenecteplase, a fibrin-specific recombinant tissue plasminogen activator, was safe and effective for the restoration of catheter function in patients with dysfunctional central venous catheters.

Is there any evidence to indicate that antibiotic-coated central venous catheters have a lower rate of infection compared with normal catheters? There are several methods by which a CVC can become ...

Stereotaxis plans to launch the MAGiC cardiac ablation catheter in early 2026, CEO and Chair David Fischel tells MassDevice.

LONDON--(BUSINESS WIRE)--The central venous catheters market is poised to grow by USD 138.10 million during 2021-2025, progressing at a CAGR of almost 3% during the forecast period. Worried about the ...